Genentech News
Most Popular Genentech Story
Biogen pays $31.5M for deal with Genentech
Biogen Idec is paying $31.5 million up front to buy itself a collaboration with Genentech on an experimental cancer therapy. GA101--a humanized anti-CD20 monoclonal antibody--is in early and... Read more...
Latest Headlines
- November 7, 2008
- October 31, 2008
- October 21, 2008
- October 10, 2008
- October 3, 2008
- October 2, 2008
- September 28, 2008
- September 9, 2008
- September 2, 2008
- August 22, 2008
- August 21, 2008
- August 13, 2008
- July 25, 2008
- July 22, 2008
- July 21, 2008
- July 8, 2008
- June 18, 2008
- June 12, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
